Literature DB >> 16703517

Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.

Douglas A Jabs1, Barbara K Martin, Michelle O Ricks, Michael S Forman.   

Abstract

BACKGROUND: The cytomegalovirus (CMV) UL97 gene can be sequenced either from blood specimens directly amplified by polymerase chain reaction (PCR) or from culture isolates, to detect resistance to ganciclovir.
METHODS: A prospective epidemiological study was conducted in which paired specimens were routinely obtained for sequencing of the UL97 gene from blood specimens (i.e., plasma and leukocytes) directly amplified by PCR and from CMV culture isolates. The specimens then were compared with each other and in terms of results of susceptibility testing and their association with progression of retinitis.
RESULTS: A total of 845 paired specimens were obtained from 165 patients with AIDS and CMV retinitis. There typically was >90% agreement between the UL97 gene sequences from blood specimens directly amplified by PCR and those from culture isolates. The agreement between phenotypic resistance and the detection of UL97 mutations was >92% for PCR-amplified blood specimens and >97% for culture isolates. Plasma and leukocytes performed similarly. Progression of retinitis was correlated with the detection of UL97 mutations in PCR-amplified blood specimens, with adjusted odds ratios of 7.02 (P=.002) for leukocytes, 9.11 (P=.02) for plasma, and 17.6 for culture isolates (P<.0001).
CONCLUSIONS: Because blood specimens directly amplified by PCR can be analyzed more rapidly than can cultures (< or =48 h vs. > or =4 weeks), sequencing the CMV UL97 gene from blood specimens directly amplified by PCR may be useful clinically.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703517      PMCID: PMC8900983          DOI: 10.1086/504270

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  56 in total

1.  Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories.

Authors:  S Chou; N S Lurain; A Weinberg; G Y Cai; P L Sharma; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury.

Authors:  E Guetta; V Guetta; T Shibutani; S E Epstein
Journal:  Circ Res       Date:  1997-07       Impact factor: 17.367

Review 3.  AIDS and ophthalmology: a period of transition.

Authors:  D A Jabs; J G Bartlett
Journal:  Am J Ophthalmol       Date:  1997-08       Impact factor: 5.258

4.  Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

Authors:  D A Jabs; C Enger; J G Bartlett
Journal:  Arch Ophthalmol       Date:  1989-01

5.  Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.

Authors:  A Erice; C Gil-Roda; J L Pérez; H H Balfour; K J Sannerud; M N Hanson; G Boivin; S Chou
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

6.  Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; J P Dunn; C Enger; M Forman; N Bressler; P Charache
Journal:  Arch Ophthalmol       Date:  1996-07

7.  Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.

Authors:  D R Hoover; Y Peng; A Saah; R Semba; R R Detels; C R Rinaldo; J P Phair
Journal:  Arch Ophthalmol       Date:  1996-07

8.  Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.

Authors:  P Pertel; R Hirschtick; J Phair; J Chmiel; L Poggensee; R Murphy
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

9.  Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.

Authors:  J P Dunn; M W MacCumber; M S Forman; P Charache; L Apuzzo; D A Jabs
Journal:  Am J Ophthalmol       Date:  1995-05       Impact factor: 5.258

10.  Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.

Authors:  Douglas A Jabs; Barbara K Martin; Michael S Forman; Larry Hubbard; J P Dunn; John H Kempen; Janet L Davis; David V Weinberg
Journal:  Am J Ophthalmol       Date:  2003-01       Impact factor: 5.258

View more
  11 in total

1.  Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.

Authors:  N K Bakshi; G A Fahle; I Sereti; H Wiley; R B Nussenblatt; H N Sen
Journal:  Eye (Lond)       Date:  2012-02-10       Impact factor: 3.775

2.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

3.  Role of molecular diagnostics in ocular microbiology.

Authors:  Parisa Taravati; Deborah Lam; Russell N Van Gelder
Journal:  Curr Ophthalmol Rep       Date:  2013-12-01

4.  CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.

Authors:  Lisa Barrett; Sharon Walmsley
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

5.  Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.

Authors:  Hart B Moss; Sai Chavala; Emil Say; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

6.  Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.

Authors:  Douglas A Jabs; Barbara K Martin; Michael S Forman
Journal:  Ophthalmology       Date:  2009-10-08       Impact factor: 12.079

7.  Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.

Authors:  Jared Castor; Linda Cook; Lawrence Corey; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

8.  Cytomegalovirus retinitis in the post-cART era.

Authors:  Alexander D Port; Rolake O Alabi; Lisa Koenig; Mrinali P Gupta
Journal:  Curr Ophthalmol Rep       Date:  2018-05-02

9.  Classification Criteria for Cytomegalovirus Retinitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

Review 10.  Cytomegalovirus infection in transplant recipients.

Authors:  Luiz Sergio Azevedo; Lígia Camera Pierrotti; Edson Abdala; Silvia Figueiredo Costa; Tânia Mara Varejão Strabelli; Silvia Vidal Campos; Jéssica Fernandes Ramos; Acram Zahredine Abdul Latif; Nadia Litvinov; Natalya Zaidan Maluf; Helio Hehl Caiaffa Filho; Claudio Sergio Pannuti; Marta Heloisa Lopes; Vera Aparecida dos Santos; Camila da Cruz Gouveia Linardi; Maria Aparecida Shikanai Yasuda; Heloisa Helena de Sousa Marques
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.